COVID-19 O O O O
Vaccines O O O O
Are O O O O
Safe O O O O
for O O O O
Children O O O O
This O O O O
article O O O O
was O O O O
posted O O O O
in O O O O
December O O O O
2021. O O O O
Guidance O O O O
around O O O O
COVID-19 O O O O
vaccination O O O O
continues O O O O
to O O O O
evolve. O O O O
Your O O O O
5-to-11-year-old O O O O
can O O O O
now O O O O
receive O O O O
the O O O O
Pfizer-BioNTech O O O O
pediatric O O O O
COVID-19 O O O O
vaccine. O O O O
In O O O O
fact, O O O O
the O O O O
Centers O O O O
for O O O O
Disease O O O O
Control O O O O
(CDC) O O O O
is O O O O
urging O O O O
parents O O O O
of O O O O
children O O O O
in O O O O
this O O O O
age O O O O
category O O O O
to O O O O
vaccinate O O O O
them O O O O
as O O O O
soon O O O O
as O O O O
possible O O O O
to O O O O
reduce O O O O
their O O O O
risk O O O O
not O O O O
only O O O O
of O O O O
infection O O O O
but O O O O
also O O O O
severe O O O O
disease O O O O
leading O O O O
to O O O O
hospitalization O O O O
or O O O O
long-term O O O O
complications. O O O O
Studies O O O O
found O O O O
the O O O O
pediatric O O O O
vaccine O O O O
to O O O O
be O O O O
nearly O O O O
91% O O O O
effective O O O O
in O O O O
preventing O O O O
symptomatic O O O O
COVID-19 O O O O
and O O O O
producing O O O O
a O O O O
robust O O O O
antibody O O O O
response--akin O O O O
to O O O O
that O O O O
seen O O O O
in O O O O
16- O O O O
to O O O O
25-year-olds—without O O O O
severe O O O O
side O O O O
effects, O O O O
such O O O O
as O O O O
illness O O O O
or O O O O
heart O O O O
conditions. O O O O
Vaccinating Reason 5 O O
children Reason 5 O O
prevents Reason 5 O O
viral Reason 5 O O
spread Reason 5 O O
Although Reason 5 O O
COVID-19 Reason 5 O O
is Reason 5 O O
less Reason 5 O O
common Reason 5 O O
and Reason 5 O O
less Reason 5 O O
dangerous Reason 5 O O
in Reason 5 O O
young Reason 5 O O
children Reason 5 O O
than Reason 5 O O
in Reason 5 O O
adults, Reason 5 O O
the Reason 5 O O
highly Reason 5 O O
contagious Reason 5 O O
Delta Reason 5 O O
variant Reason 5 O O
has Reason 5 O O
increased Reason 5 O O
the Reason 5 O O
number Reason 5 O O
of Reason 5 O O
pediatric Reason 5 O O
infections, Reason 5 O O
according Reason 5 O O
to Reason 5 O O
Dr. Reason 5 O O
Sallie Reason 5 O O
Permar, Reason 5 O O
the Reason 5 O O
Nancy Reason 5 O O
C. Reason 5 O O
Paduano Reason 5 O O
Professor Reason 5 O O
of Reason 5 O O
Pediatrics. Reason 5 O O
As Reason 5 O O
of Reason 5 O O
late Reason 5 O O
October, Reason 5 O O
more Reason 5 O O
than Reason 5 O O
six Reason 5 O O
million Reason 5 O O
U.S. Reason 5 O O
children Reason 5 O O
tested Reason 5 O O
positive Reason 5 O O
for Reason 5 O O
the Reason 5 O O
SARS-CoV-2 Reason 5 O O
virus, Reason 5 O O
Dr. Reason 5 O O
Permar Reason 5 O O
says. Reason 5 O O
"Children Reason 5 O O
became Reason 5 O O
25% Reason 5 O O
of Reason 5 O O
all Reason 5 O O
of Reason 5 O O
the Reason 5 O O
COVID-19 Reason 5 O O
infections Reason 5 O O
that Reason 5 O O
were Reason 5 O O
being Reason 5 O O
reported," Reason 5 O O
she Reason 5 O O
says. Reason 5 O O
This Reason 5 O O
percentage Reason 5 O O
includes Reason 5 O O
children Reason 5 O O
who Reason 5 O O
got Reason 5 O O
infected Reason 5 O O
during Reason 5 O O
the Reason 5 O O
winter Reason 5 O O
surge, Reason 5 O O
as Reason 5 O O
well Reason 5 O O
as Reason 5 O O
those Reason 5 O O
whose Reason 5 O O
infections Reason 5 O O
occurred Reason 5 O O
over Reason 5 O O
the Reason 5 O O
summer Reason 5 O O
as Reason 5 O O
the Reason 5 O O
Delta Reason 5 O O
variant Reason 5 O O
became Reason 5 O O
the Reason 5 O O
dominant Reason 5 O O
strain. Reason 5 O O
"When Reason 5 O O
more Reason 5 O O
children Reason 5 O O
are Reason 5 O O
infected, Reason 5 O O
viral Reason 5 O O
spread Reason 5 O O
increases, Reason 5 O O
as Reason 5 O O
does Reason 5 O O
the Reason 5 O O
potential Reason 5 O O
for Reason 5 O O
new Reason 5 O O
variants Reason 5 O O
to Reason 5 O O
appear," Reason 5 O O
she Reason 5 O O
says. Reason 5 O O
Dr. Reason 5 O O
Emily Reason 5 O O
Wasserman, Reason 5 O O
assistant Reason 5 O O
professor Reason 5 O O
of Reason 5 O O
pediatrics, Reason 5 O O
stresses, Reason 5 O O
"Children Reason 5 O O
are Reason 5 O O
a Reason 5 O O
chain Reason 5 O O
of Reason 5 O O
transmission Reason 5 O O
for Reason 5 O O
this Reason 5 O O
virus. Reason 5 O O
We Reason 5 O O
can Reason 5 O O
often Reason 5 O O
protect Reason 5 O O
them Reason 5 O O
against Reason 5 O O
transmission Reason 5 O O
with Reason 5 O O
masking Reason 5 O O
in Reason 5 O O
schools, Reason 5 O O
but Reason 5 O O
when Reason 5 O O
they Reason 5 O O
come Reason 5 O O
home, Reason 5 O O
they Reason 5 O O
can Reason 5 O O
spread Reason 5 O O
the Reason 5 O O
virus Reason 5 O O
to Reason 5 O O
individuals Reason 5 O O
in Reason 5 O O
the Reason 5 O O
household, Reason 5 O O
especially Reason 5 O O
those Reason 5 O O
who Reason 5 O O
are Reason 5 O O
vulnerable Reason 5 O O
because O O O O
of O O O O
autoimmune O O O O
diseases O O O O
or O O O O
immunosuppressant O O O O
conditions." O O O O
The O O O O
CDC O O O O
reports O O O O
that O O O O
the O O O O
proliferation O O O O
of O O O O
Delta O O O O
led O O O O
to O O O O
a O O O O
fivefold O O O O
increase O O O O
in O O O O
COVID-19-related O O O O
hospitalizations O O O O
from O O O O
late O O O O
June O O O O
to O O O O
mid-August. O O O O
"Notably, Reason 1 O O
there've Reason 1 O O
been Reason 1 O O
over Reason 1 O O
400 Reason 1 O O
deaths Reason 1 O O
from Reason 1 O O
this Reason 1 O O
virus Reason 1 O O
in Reason 1 O O
children, Reason 1 O O
so Reason 1 O O
this Reason 1 O O
is Reason 1 O O
a Reason 1 O O
deadly Reason 1 O O
and Reason 1 O O
severe Reason 1 O O
virus Reason 1 O O
infection Reason 1 O O
for Reason 1 O O
children," Reason 1 O O
Dr. Reason 1 O O
Permar Reason 1 O O
says. Reason 1 O O
COVID-19, O O O O
not O O O O
the O O O O
vaccine, O O O O
causes O O O O
myocarditis O O O O
Although O O O O
the O O O O
Pfizer O O O O
and O O O O
Moderna O O O O
vaccines O O O O
have O O O O
been O O O O
linked O O O O
to O O O O
an O O O O
increased O O O O
risk O O O O
of O O O O
myocarditis O O O O
(inflammation O O O O
of O O O O
the O O O O
heart O O O O
muscle) O O O O
and O O O O
pericarditis O O O O
(inflammation O O O O
of O O O O
the O O O O
lining O O O O
outside O O O O
the O O O O
heart) O O O O
in O O O O
some O O O O
individuals—particularly O O O O
in O O O O
males O O O O
ages O O O O
16 O O O O
to O O O O
29—the O O O O
risk O O O O
is O O O O
rare: O O O O
fewer O O O O
than O O O O
400 O O O O
cases O O O O
have O O O O
occurred O O O O
among O O O O
the O O O O
more O O O O
than O O O O
8 O O O O
million O O O O
children O O O O
and O O O O
adolescents O O O O
who O O O O
have O O O O
received O O O O
the O O O O
COVID-19 O O O O
vaccine, O O O O
Dr. O O O O
Permar O O O O
says. O O O O
In Reason 5 O O
a Reason 5 O O
study Reason 5 O O
of Reason 5 O O
1500 Reason 5 O O
children Reason 5 O O
who Reason 5 O O
received Reason 5 O O
the Reason 5 O O
vaccine, Reason 5 O O
no Reason 5 O O
serious Reason 5 O O
cases Reason 5 O O
of Reason 5 O O
myocarditis Reason 5 O O
occurred, Reason 5 O O
she Reason 5 O O
says. Reason 5 O O
"There Reason 5 O O
were Reason 5 O O
also, Reason 5 O O
importantly, Reason 5 O O
no Reason 5 O O
anaphylaxis Reason 5 O O
or Reason 5 O O
severe Reason 5 O O
allergies," Reason 5 O O
she Reason 5 O O
adds. Reason 5 O O
Virus-associated O O O O
myocarditis, O O O O
which O O O O
often O O O O
requires O O O O
life-saving O O O O
interventions, O O O O
intensive O O O O
drug O O O O
treatment, O O O O
often O O O O
intubation, O O O O
and O O O O
sometimes O O O O
a O O O O
system O O O O
to O O O O
pump O O O O
blood O O O O
for O O O O
the O O O O
heart--is O O O O
more O O O O
likely O O O O
to O O O O
occur O O O O
after O O O O
infection O O O O
with Reason 1 O O
COVID-19 Reason 1 O O
than Reason 1 O O
from Reason 1 O O
the Reason 1 O O
vaccine, Reason 1 O O
Dr. Reason 1 O O
Permar Reason 1 O O
explains, Reason 1 O O
noting Reason 1 O O
that Reason 1 O O
none Reason 1 O O
of Reason 1 O O
these Reason 1 O O
events Reason 1 O O
has Reason 1 O O
occurred Reason 1 O O
in Reason 1 O O
vaccinated Reason 1 O O
children. Reason 1 O O
"It's Reason 1 O O
much Reason 1 O O
more Reason 1 O O
important Reason 1 O O
to Reason 1 O O
prevent O O O O
virus-associated O O O O
myocarditis O O O O
through O O O O
vaccination O O O O
than O O O O
to O O O O
forgo O O O O
vaccination O O O O
on O O O O
the O O O O
small O O O O
chance O O O O
of O O O O
a O O O O
vaccine-associated O O O O
self-limited O O O O
myocarditis." O O O O
Any O O O O
vaccine O O O O
side O O O O
effects O O O O
that O O O O
do O O O O
occur O O O O
in O O O O
young O O O O
children--pain O O O O
at O O O O
the O O O O
injection O O O O
site, O O O O
fatigue, O O O O
headache, O O O O
chills, O O O O
muscle O O O O
or O O O O
joint O O O O
aches, O O O O
and O O O O
fever--are O O O O
generally O O O O
milder O O O O
and O O O O
less O O O O
frequent O O O O
than O O O O
those O O O O
observed O O O O
in O O O O
adolescents, O O O O
and O O O O
usually O O O O
disappear O O O O
within O O O O
one O O O O
to O O O O
three O O O O
days. O O O O
Vaccine Reason 5 O O
effects Reason 5 O O
on Reason 5 O O
children's Reason 5 O O
lives Reason 5 O O
Among Reason 5 O O
the Reason 5 O O
pediatric Reason 5 O O
vaccine's Reason 5 O O
many Reason 5 O O
benefits Reason 5 O O
is Reason 5 O O
protection Reason 5 O O
against Reason 5 O O
a Reason 5 O O
rare Reason 5 O O
but Reason 5 O O
serious Reason 5 O O
complication Reason 5 O O
of Reason 5 O O
severe Reason 5 O O
COVID-19 Reason 5 O O
known Reason 5 O O
as Reason 5 O O
multi-system Reason 5 O O
inflammatory Reason 5 O O
syndrome Reason 5 O O
or Reason 5 O O
MIS-C. Reason 5 O O
More Reason 5 O O
than Reason 5 O O
5,000 Reason 5 O O
cases Reason 5 O O
of Reason 5 O O
MIS-C—approximately Reason 5 O O
one O O O O
in O O O O
3,200 O O O O
infections--have O O O O
been O O O O
reported O O O O
nationally, O O O O
Dr. O O O O
Permar O O O O
says. O O O O
"Almost O O O O
half O O O O
of O O O O
those O O O O
cases O O O O
have O O O O
been O O O O
in O O O O
the O O O O
age O O O O
group O O O O
for O O O O
which O O O O
the O O O O
vaccine O O O O
has O O O O
just O O O O
been O O O O
approved," O O O O
she O O O O
says. O O O O
"Three O O O O
diseases O O O O
are O O O O
now O O O O
vaccine-preventable: O O O O
severe O O O O
COVID-19 O O O O
respiratory O O O O
disease O O O O
that O O O O
can O O O O
land O O O O
children O O O O
in O O O O
the O O O O
ICU O O O O
for O O O O
respiratory O O O O
disease, O O O O
MIS-C, O O O O
and O O O O
long O O O O
COVID, O O O O
which O O O O
leaves O O O O
individuals O O O O
unable O O O O
to O O O O
fully O O O O
gain O O O O
back O O O O
all O O O O
of O O O O
their O O O O
ability O O O O
to O O O O
perform O O O O
their O O O O
daily O O O O
activities, O O O O
and O O O O
to O O O O
suffer O O O O
from O O O O
long-term O O O O
fatigue O O O O
or O O O O
shortness O O O O
of O O O O
breath, Reason 5 O O
depression, Reason 5 O O
or Reason 5 O O
persistent Reason 5 O O
neurologic Reason 5 O O
symptoms," Reason 5 O O
Dr. Reason 5 O O
Permar Reason 5 O O
says. Reason 5 O O
"The O O O O
best O O O O
defense O O O O
against O O O O
all O O O O
of O O O O
these O O O O
is O O O O
the Reason 5 O O
COVID-19 Reason 5 O O
vaccine." Reason 5 O O
Like Reason 5 O O
older Reason 5 O O
children Reason 5 O O
and Reason 5 O O
adults, Reason 5 O O
young Reason 5 O O
children Reason 5 O O
will Reason 5 O O
receive Reason 5 O O
two Reason 5 O O
vaccine Reason 5 O O
doses, Reason 5 O O
three Reason 5 O O
weeks Reason 5 O O
apart. Reason 5 O O
The Reason 5 O O
main Reason 5 O O
difference Reason 5 O O
between Reason 5 O O
the Reason 5 O O
pediatric Reason 5 O O
and Reason 5 O O
adult Reason 5 O O
COVID-19 Reason 5 O O
vaccines Reason 5 O O
are Reason 5 O O
dosage Reason 5 O O
sizes Reason 5 O O
and Reason 5 O O
delivery: Reason 5 O O
each Reason 5 O O
pediatric Reason 5 O O
dose Reason 5 O O
will Reason 5 O O
contain Reason 5 O O
one-third Reason 5 O O
the Reason 5 O O
amount Reason 5 O O
of Reason 5 O O
that Reason 5 O O
given Reason 5 O O
to Reason 5 O O
adolescents O O O O
and O O O O
adults. O O O O
It O O O O
will O O O O
also O O O O
be O O O O
administered O O O O
through O O O O
a O O O O
smaller O O O O
needle. O O O O
According O O O O
to O O O O
Pfizer's O O O O
research, O O O O
the O O O O
smaller O O O O
dose O O O O
produced O O O O
as O O O O
strong O O O O
an O O O O
immune O O O O
response O O O O
in O O O O
5-to-11-year-olds, O O O O
as O O O O
in O O O O
16- O O O O
to O O O O
25-year-olds, O O O O
who O O O O
received O O O O
a O O O O
higher O O O O
dose. O O O O
The O O O O
smaller O O O O
dose O O O O
is O O O O
as O O O O
effective O O O O
because O O O O
young O O O O
children's O O O O
immune O O O O
systems O O O O
are O O O O
stronger O O O O
than O O O O
those O O O O
of O O O O
adults. O O O O
Other O O O O
pediatric O O O O
COVID-19 O O O O
vaccines O O O O
are O O O O
under O O O O
review. O O O O
Currently, O O O O
the O O O O
U.S. O O O O
Food O O O O
and O O O O
Drug O O O O
Administration O O O O
(FDA) O O O O
is O O O O
reviewing O O O O
Moderna's O O O O
vaccine O O O O
for O O O O
6-to-11-year-olds. O O O O
Meanwhile, O O O O
Moderna O O O O
and O O O O
Pfizer O O O O
are O O O O
both O O O O
conducting O O O O
clinical O O O O
trials O O O O
of O O O O
their O O O O
vaccines O O O O
in O O O O
children O O O O
ages O O O O
6 O O O O
months O O O O
to O O O O
4 O O O O
years. O O O O
Johnson O O O O
& O O O O
Johnson O O O O
is O O O O
conducting O O O O
trials O O O O
in O O O O
children O O O O
ages O O O O
12 O O O O
to O O O O
17. O O O O
Says O O O O
Dr. O O O O
Permar, O O O O
"We O O O O
will O O O O
be O O O O
dealing O O O O
with O O O O
this O O O O
pandemic O O O O
until O O O O
we O O O O
have O O O O
immunity O O O O
in O O O O
all O O O O
of O O O O
our O O O O
populations, O O O O
and O O O O
children O O O O
is O O O O
where O O O O
the O O O O
biggest O O O O
